Clinical trial

MRI-Ultrasound Fusion or Cognitive Registration in MR-targeted Prostate Biopsy

NCT04953351

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

PROCEDURE · Unmapped registry intervention Cognitive registration targeted biopsy and TRUS-system biopsy Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention MRI-ultrasound fusion targeted biopsy and TRUS-system biopsy Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

MRI-Ultrasound Fusion or Cognitive Registration in MR-targeted Prostate Biopsy

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2021-08-01

PhaseNA

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

Cognitive registration targeted biopsy and TRUS-system biopsyPROCEDURE

MRI-ultrasound fusion targeted biopsy and TRUS-system biopsyPROCEDURE

Sponsors & collaborators

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical Schoollead sponsor

Mapped research locations

NanjingJiangsu, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04953351 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.